bevacizumab,nivolumab,ribociclib,abemaciclib,tegafur,oxaliplatin,atezolizumab,oteracil,gimeracil,capecitabine,Imetelstat
nordic group,bms,eli lilly,roche,novartis,otsuka,ono pharma,geron corporation
['bcsm', 'natalee', 'gastric', 'gism', 'abema', '#gi', 'breast', 'monarche,(-monarcher)', 'imbrave050', 'abemaciclib', 'hcc', 'attraction5', 'monarche', 'mds', 'ribociclib']
day 1 #asco23 highlights: 1. #natalee: adj #ribociclib hr+ breast ca 2. monarche: adj #abemaciclib update 3. #attraction5: adj gastric ca 4. #imbrave050: adj hcc 5. ofs in premenopausal 6. #imerge imetelstat mds #bcsm #gism #onctwitter #medtwitter 1/7
Practice changing 🗣 for community oncologists: w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own. COI: https://t.co/cJOjp0RvQE